RETRACTED: Limbal stem cell deficiency secondary to systemic daptopotamab deruxtecan (Dato-DXd): A case report and literature review.

Chi YC, Chiu LY, Hsu SL.

Open source

DOI
10.1177/11206721231169538
Published
2023-04-18
Container
Eur J Ophthalmol
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/11206721231169538,
  title = {RETRACTED: Limbal stem cell deficiency secondary to systemic daptopotamab deruxtecan (Dato-DXd): A case report and literature review.},
  author = {Chi YC and  Chiu LY and  Hsu SL.},
  year = {2023},
  journal = {Eur J Ophthalmol},
  doi = {10.1177/11206721231169538},
  url = {https://doi.org/10.1177/11206721231169538}
}

RIS

TY  - JOUR
TI  - RETRACTED: Limbal stem cell deficiency secondary to systemic daptopotamab deruxtecan (Dato-DXd): A case report and literature review.
AU  - Chi YC
AU  -  Chiu LY
AU  -  Hsu SL.
PY  - 2023
JO  - Eur J Ophthalmol
DO  - 10.1177/11206721231169538
UR  - https://doi.org/10.1177/11206721231169538
ER  - 

APA

YC, C., LY, C., & SL., H. (2023). RETRACTED: Limbal stem cell deficiency secondary to systemic daptopotamab deruxtecan (Dato-DXd): A case report and literature review.. Eur J Ophthalmol. https://doi.org/10.1177/11206721231169538

Source records